Oncogenic KRAS Induces Arginine Auxotrophy and Confers a Therapeutic Vulnerability to SLC7A1 Inhibition in Non–Small Cell Lung Cancer
2024 · Cancer Research · 27 citations
https://doi.org/10.1158/0008-5472.can-23-2095
Y
Ying Zheng
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
17
Papers
45
Citations
2
h-index
2
i10-index
Ying Zheng is an academic researcher from Zhejiang Chinese Medical University. The author has contributed to research in topics: Cancer Research and Treatments & Metabolism and Genetic Disorders & Cancer, Hypoxia, and Metabolism. The author has an h-index of 2, co-authored 15 publications.
ORCID: 0009-0008-6129-5101Papers by this author
worksTable S1 from Oncogenic KRAS Induces Arginine Auxotrophy and Confers a Therapeutic Vulnerability to SLC7A1 Inhibition in Non–Small Cell Lung Cancer
2024 · 0 citations
https://doi.org/10.1158/0008-5472.26037516.v1
Data from Oncogenic KRAS Induces Arginine Auxotrophy and Confers a Therapeutic Vulnerability to SLC7A1 Inhibition in Non–Small Cell Lung Cancer
2024 · 0 citations
https://doi.org/10.1158/0008-5472.c.7285938
Table S1 from Oncogenic KRAS Induces Arginine Auxotrophy and Confers a Therapeutic Vulnerability to SLC7A1 Inhibition in Non–Small Cell Lung Cancer
2024 · 0 citations
https://doi.org/10.1158/0008-5472.26037516
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat